Antigenics
(OTC) ANTI
Antigenics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
N/A
Net Income (TTM)
N/A
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
9.46 (High)
Dividend
$0.00
Beta (Volatility)
9.46 (High)
Price
$0.00
Volume
337,965
Open
$0.00
Price
$0.00
Volume
337,965
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
9.46 (High)
Price
$0.00
Volume
337,965
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
ANTI News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Antigenics
ANTI Financials
Key Financial Metrics (TTM)
Gross Margin
N/A
Operating Margin
N/A
Net Income Margin
N/A
Return on Equity
0%
Return on Capital
N/A
Return on Assets
N/A
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
N/A
Stock Overview
Market Cap
$0.00
Shares Outstanding
0
Volume
337.96K
Avg. Volume
0
Financials (TTM)
Gross Profit
N/A
Operating Income
N/A
EBITDA
N/A
Operating Cash Flow
N/A
Capital Expenditure
N/A
Free Cash Flow
N/A
Cash & ST Invst.
N/A
Total Debt
N/A
Antigenics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
N/A
N/A
Gross Profit
N/A
N/A
Gross Margin
N/A
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
N/A
N/A
EBITDA
N/A
N/A
Quarterly Fundamentals
Net Cash
N/A
N/A
Accounts Receivable
N/A
N/A
Inventory
N/A
N/A
Long Term Debt
N/A
N/A
Short Term Debt
N/A
N/A
Return on Assets
N/A
N/A
Return on Invested Capital
N/A
N/A
Free Cash Flow
N/A
N/A
Operating Cash Flow
N/A
N/A